Cargando…
A glance at the emerging diagnostic biomarkers in the most prevalent genitourinary cancers
Genitourinary cancers comprise of a heterogenous group of cancers of which renal cell carcinoma, urothelial bladder carcinoma, and prostate adenocarcinoma are the most commonly encountered subtypes. A lot of research is ongoing using various strategies for exploration of novel biomarkers for genitou...
Autor principal: | Merae Alshahrani, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073037/ https://www.ncbi.nlm.nih.gov/pubmed/35531253 http://dx.doi.org/10.1016/j.sjbs.2022.01.017 |
Ejemplares similares
-
Exosomes in Genitourinary Cancers: Emerging Mediators of Drug Resistance and Promising Biomarkers
por: Lu, Zeyi, et al.
Publicado: (2023) -
Editorial: Emerging Biomarkers in Genitourinary Tumors
por: Montironi, Rodolfo, et al.
Publicado: (2019) -
Emerging therapeutic agents for genitourinary cancers
por: Zarrabi, Kevin, et al.
Publicado: (2019) -
Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?
por: Cova, Ilaria, et al.
Publicado: (2018) -
Evaluation and Management of Genitourinary Emergencies in Patients with Cancer
por: Lipe, Demis N., et al.
Publicado: (2021)